Company intelligence / Profile preview

Bioveta

Ivanovice na Hané, South Moravian, Czech Republicbioveta.eu ↗

Ownership: Private
Employees: ~684
Development stage: Other

Overview

Bioveta is a leading Czech manufacturer of veterinary pharmaceuticals with over 200 products across 15 categories. Its portfolio is dominated by vaccines (68.5% of sales), followed by antiparasitics and hormones. The company has an established international presence with exports to over 100 countries. It has developed both prophylactic vaccines for major animal diseases—including swine fever—and therapeutic agents such as antibiotics for mastitis and respiratory disease.

Therapeutic areas: DermatologyHematologyEndocrinologyInfectious Diseases
Modalities: VaccineSmall moleculeRecombinant proteinAntibiotic (Small molecule)Hormone (Small molecule and biologic)
Industry: Veterinary

Partnerships

Boehringer Ingelheim Animal Health

Beyond the preview

Go deeper on Bioveta.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bioveta.

Explore the full profile